Laparoscopic placement of PAP catheters for intraperitoneal chemotherapy in ovarian carcinoma

被引:16
作者
Arts, HJG
Willemse, PHB
Tinga, DJ
de Vries, EGE
van der Zee, AGJ
机构
[1] Univ Groningen Hosp, Dept Gynaecol, Groningen, Netherlands
[2] Univ Groningen Hosp, Dept Med Oncol, Groningen, Netherlands
关键词
D O I
10.1006/gyno.1998.4968
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To our report our experience with the laparoscopic placement of peritoneal access ports and to compare it to our experience with placement at laparotomy. Methods. Patients with advanced ovarian carcinoma were enrolled in a study to receive intraperitoneal paclitaxel in combination with intravenous cisplatin and cyclophosphamide as first-or second-line chemotherapy. Patients had a PAP catheter placed at primary laparotomy or by a separate laparoscopic procedure under general anesthesia. Results. In 13 patients a PAP catheter was placed during primary laparotomy, without complications. Thirteen patients had laparoscopic catheter placing, using routine Veress needle insufflation. After a bowel perforation at insertion of the umbilical trocar had occurred in one patient, due to extensive adhesions, we decided to use only an open laparoscopic procedure. No other procedure or catheter-related complications occurred. Conclusion. Laparoscopic-assisted placement of PAP catheters is feasible, but should preferably be performed by an open laparoscopic procedure in this patient population at risk for intraabdominal adhesions. (C) 1998 Academic Press.
引用
收藏
页码:32 / 35
页数:4
相关论文
共 21 条
[1]   Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer [J].
Alberts, DS ;
Liu, PY ;
Hannigan, EV ;
OToole, R ;
Williams, SD ;
Young, JA ;
Franklin, EW ;
ClarkePearson, DL ;
Malviya, VK ;
DuBeshter, B ;
Adelson, MD ;
Hoskins, WJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (26) :1950-1955
[2]   A retrospective analysis of laparoscopically assisted ventriculoperitoneal shunts [J].
Box, JC ;
Young, D ;
Mason, E ;
Angood, P ;
Yancey, M ;
Schiess, R ;
Duncan, T ;
Lucas, GW .
SURGICAL ENDOSCOPY-ULTRASOUND AND INTERVENTIONAL TECHNIQUES, 1996, 10 (03) :311-313
[3]  
Brownlee J, 1997, CLIN NEPHROL, V47, P122
[4]   MEDICAL PROGRESS - CANCER OF THE OVARY [J].
CANNISTRA, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (21) :1550-1559
[5]  
DEDRICK RL, 1985, SEMIN ONCOL, V12, P1
[6]   PHASE-II STUDY OF INTRAPERITONEAL CISPLATIN PLUS SYSTEMIC ETOPOSIDE AS 2ND-LINE TREATMENT IN PATIENTS WITH SMALL-VOLUME RESIDUAL OVARIAN-CANCER [J].
DEJONG, RS ;
WILLEMSE, PHB ;
BOONSTRA, H ;
DEVRIES, EGE ;
VANDERGRAAF, WTA ;
SLEIJFER, DT ;
VANDERZEE, AGJ ;
MULDER, NH .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (05) :709-713
[7]  
DUNTON CJ, 1997, SEMIN ONCOL, V23, pS5
[8]   PHASE-I FEASIBILITY AND PHARMACOLOGICAL STUDY OF WEEKLY INTRAPERITONEAL PACLITAXEL - A GYNECOLOGIC-ONCOLOGY-GROUP PILOT-STUDY [J].
FRANCIS, P ;
ROWINSKY, E ;
SCHNEIDER, J ;
HAKES, T ;
HOSKINS, W ;
MARKMAN, M .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (12) :2961-2967
[9]  
HASSON HM, 1974, J REPROD MED, V12, P234
[10]  
*INT FED GYN OBST, 1987, AM J OBSTET GYNECOL, V156, P36